PRKCD and type 1 diabetes mellitus: Furthermore, it was shown that the deletion of PKCδ in pancreatic islets protects from cytokine-induced apoptosis, NO generation, and also disrupts toll-like receptor 2 (TLR2) signaling, which activation contributes to the development of type 1 diabetes [128–130].